Literature DB >> 10768958

Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells.

K Lukin1, M Cosyns, T Mitchell, M Saffry, A Hayward.   

Abstract

CD154 is necessary for mice to clear a Cryptosporidium parvum infection, but whether this ligand has to be expressed on T cells with specificity for C. parvum has not been determined. We infected DO11.10 (ovalbumin specific) T-cell receptor transgenic mice that had been bred to a RAG(-/-) background with C. parvum and found that the infection was cleared within 6 weeks, while RAG(-/-) controls were unable to clear C. parvum infection. Recovery was accompanied by an increase in the number of splenic T cells with the CD44(high) phenotype that characterizes memory cells. To determine whether a C. parvum-infected environment sufficed to activate transgenic T cells, we reconstituted C. parvum-infected BALB/c SCID mice with DO11.10 RAG(-/-) splenocytes. Fecal excretion of C. parvum antigen ceased in the 12 weeks following the adoptive transfer, unless the mice were also injected with tolerizing doses of ovalbumin. DO11.10 T cells were found in the submucosa of C. parvum-infected, but not uninfected, BALB/c SCID hosts within 48 h of injection. The transferred DO11.10 T cells divided and acquired a CD44(high) memory phenotype in C. parvum-infected, but not uninfected, recipients. DO11.10 splenocytes from CD154 knockout donors failed to clear a C. parvum infection, confirming a requirement for CD154 in recovery. In vitro, the DO11.10 cells did not proliferate in response to C. parvum antigen, and a tBlast GenBank search revealed no matches between the ovalbumin peptide and C. parvum DNA sequences. C. parvum-infected SCID mice given RAG(-/-) CD8(+) T cells with a Listeria-specific transgene did not recover from C. parvum infection. Our data suggest that antigen-nonspecific CD4(+) T-cell effector mechanisms in combination with the innate arm of the immune system are sufficient for the eradication of C. parvum infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768958      PMCID: PMC97473          DOI: 10.1128/IAI.68.5.2663-2670.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.

Authors:  M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1987-04       Impact factor: 1.276

2.  Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity.

Authors:  B L Ungar; T C Kao; J A Burris; F D Finkelman
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

3.  Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice.

Authors:  W Chen; J A Harp; A G Harmsen; E A Havell
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

4.  Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice.

Authors:  V McDonald; G J Bancroft
Journal:  Parasite Immunol       Date:  1994-06       Impact factor: 2.280

5.  Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.

Authors:  J White; K M Haskins; P Marrack; J Kappler
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

6.  Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: the importance of intestinal microflora.

Authors:  J A Harp; W Chen; A G Harmsen
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

7.  Crude extract and recombinant protein of Cryptosporidium parvum oocysts induce proliferation of human peripheral blood mononuclear cells in vitro.

Authors:  M A Gomez Morales; C M Ausiello; F Urbani; E Pozio
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

8.  Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice.

Authors:  L E Perryman; P H Mason; C E Chrisp
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection.

Authors:  S A Aguirre; P H Mason; L E Perryman
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 10.  Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".

Authors:  R A Kroczek; D Graf; D Brugnoni; S Giliani; U Korthüer; A Ugazio; G Senger; H W Mages; A Villa; L D Notarangelo
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988

View more
  5 in total

1.  An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice.

Authors:  Brett A Leav; Masaru Yoshida; Kathleen Rogers; Seth Cohen; Nihal Godiwala; Richard S Blumberg; Honorine Ward
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection.

Authors:  A R Hayward; M Cosyns; M Jones; E M Ponnuraj
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins.

Authors:  Maria Angeles Gomez Morales; Raffaella Mele; Alessandra Ludovisi; Fabrizio Bruschi; Fabio Tosini; Rachele Riganò; Edoardo Pozio
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

4.  Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum.

Authors:  Dan Takeuchi; Vickie C Jones; Makiko Kobayashi; Fujio Suzuki
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

5.  A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival.

Authors:  Joanne Turner; Karen M Dobos; Marc A Keen; Anthony A Frank; Stefan Ehlers; Ian M Orme; John T Belisle; Andrea M Cooper
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.